Your mission is to apply your deep expertise in in vivo pharmacology to drive the preclinical evaluation of our innovative Bicycle® Radio Conjugates (BRCs). By independently executing and interpreting key preclinical studies, you will generate the critical data needed to understand their activity, guide their optimization, and support the advancement of our next-generation cancer therapies.
Working location: This role can initially be based remotely, with a requirement to travel to the Cambridge office once per week. We estimate that from early 2027 the position will have a hybrid attendance at our office in London (up to 4 days per week), in the vicinity of Kings Cross, with an ongoing requirement to visit the Cambridge Office up to 2 days per month.
YOUR RESPONSIBILITIES
Scientific & Project Execution